Locust Walk Acquisition
General Information | |
Business: | We intend to focus on healthcare and healthcare-related businesses in the United States and Europe, with a priority on companies in the life sciences sector. Our sponsor is an affiliate of Locust Walk Partners, a leading global life sciences transaction firm. Since its founding in 2008, Locust Walk Partners has focused exclusively on the healthcare industry, where it works with emerging life sciences companies to complete transformative transactions, including global or regional partnerships, mergers and acquisitions, and financings. Locust Walk Partners teams up with life sciences companies to help them define and implement their research and development, corporate development, business development and/or financing strategies. Locust Walk Partners then assists in executing on those strategies through one or more transactions, including licensing transactions, mergers and acquisitions, and raising capital on a global and/or regional basis. Locust Walk Partners’ clients include private and public biopharmaceutical companies developing innovative therapies at all stages of development, as well as medical device, diagnostic and digital health companies. |
Industry: | BLANK CHECKS |
Employees: | 0 |
Founded: | 2020 |
Contact Information | |
Address | c/o Ledgewood PC Two Commerce Square 2001 Market Street, Suite 3400 Philadelphia, PA 19103 |
Phone Number | (215) 731-9450 |
Web Address | |
View Prospectus: | Locust Walk Acquisition |
Financial Information | |
Market Cap | $163mil |
Revenues | $0 mil (last 12 months) |
Net Income | $0 mil (last 12 months) |
IPO Profile | |
Symbol | LWACU |
Exchange | NASDAQ |
Shares (millions): | 15.3 |
Price range | $10.00 - $10.00 |
Est. $ Volume | $153.0 mil |
Manager / Joint Managers | Cantor Fitzgerald |
CO-Managers | - |
Expected To Trade: | 1/8/2021 |
Status: | Priced |
Quiet Period Expiration Date: | Available only to Subscribers |
Lock-Up Period Expiration Date: | Available only to Subscribers |
SCOOP Rating | Available only to Subscribers |
Rating Change | Available only to Subscribers |